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Abstract 
Background: Efficient gene editing is a critical tool for investigating molecular mechanisms of cellular processes 
and engineering organisms for numerous purposes ranging from biotechnology to medicine. Recently developed 
RNA‑guided CRISPR/Cas9 technology has been used for efficient gene editing in various organisms, but has not been 
tested in a model filamentous fungus, Neurospora crassa.
Findings: In this report, we demonstrate efficient gene replacement in a model filamentous fungus, Neurospora 
crassa, with the CRISPR/Cas9 system. We utilize Cas9 endonuclease and single crRNA:tracrRNA chimeric guide RNA 
(gRNA) to: (1) replace the endogenous promoter of clr‑2 with the β‑tubulin promoter, and (2) introduce a codon opti‑
mized fire fly luciferase under the control of the gsy‑1 promoter at the csr‑1 locus. CLR‑2 is one of the core transcrip‑
tion factors that regulate the expression of cellulases, and GSY‑1 regulates the conversion of glucose into glycogen. 
We show that the β‑tubulin promoter driven clr‑2 strain shows increased expression of cellulases, and gsy‑1‑luciferase 
reporter strain can be easily screened with a bioluminescence assay.
Conclusion: CRISPR/Cas9 system works efficiently in Neurospora crassa, which may be adapted to Neurospora natu‑
ral isolates and other filamentous fungi. It will be beneficial for the filamentous fungal research community to take 
advantage of CRISPR/Cas9 tool kits that enable genetic perturbations including gene replacement and insertions.
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Findings
Genetic engineering of organisms of interest are criti-
cal tools to elucidate molecular and cellular processes or 
to engineer organisms with new characteristics or traits. 
Clustered regularly interspaced short palindromic repeats 
(CRISPR)-associated RNA-guided DNA endonuclease, 
Cas9, has been driving the latest gene editing technol-
ogy by taking advantage of the simple design of a single 
crRNA:tracrRNA chimeric guide RNA (gRNA). gRNA 
includes 20 base pairs of target sequences that causes 
double strand breaks by Cas9 at the target locus, which 
triggers gene replacement by homologous recombination 
(HR) [1–3] (reviewed by Hsu et al. [4]). CRISPR/Cas9 sys-
tem has been utilized for gene editing ranging from yeast 
to human cells including filamentous fungi [5–8].
A model filamentous fungus, Neurospora crassa, has 
been used to elucidate fundamental molecular mecha-
nisms including the one gene-one enzyme hypothesis, 
cell fusion, circadian rhythms, and epigenetics among 
others [9]. Gene editing by HR was a difficult task in N. 
crassa until the discovery of highly efficient gene replace-
ment in Neurospora strains lacking mus-51 (NCU08290) 
or mus-52 (NCU00077), which are deficient in non-
homologous end-joining [10]. This finding facilitated 
the high-throughput generation of single gene deletion 
knockout (KO) collection of N. crassa [11]. However, one 
has to backcross Neurospora transformants to wild type 
in order to eliminate mus-51 or mus-52 KO background, 
which may take anywhere between one to three months. 
More importantly, there are numerous Neurospora natu-
ral isolates that are difficult to generate initial mus-51 or 
mus-52 KO, which make gene editing difficult. Therefore, 
it is critical to establish an alternative gene editing tech-
nology for the Neurospora system.
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The design of the CRISPR/Cas9 system consists of Cas9 
DNA endonuclease and a guide RNA (gRNA) (Figure 1a). 
Cas9 is fused to the trpC (AN0648) promoter from the 
Aspergillus nidulans followed by both SV40 nuclear 
localization signal (NLS) domain and the trpC termina-
tor sequence from the A. nidulans (Figure 1b) [12]. gRNA 
is fused to Small Nucleolar RNA 52 (SNR52) promoter 
from the Saccharomyces cerevisiae [13] and includes 
specific 20 base pair target sequences followed by gRNA 
structural component and SUP4 flanking region (Fig-
ure 1b). The promoter of SNR52 has been used to express 
gRNA in S. cerevisiae [14]. We designed target sequences 
for clr-2 (NCU08042) and csr-1 (NCU00726) loci fol-
lowed by protospacer adjacent motif (PAM) (Figure 1c), 
which is required for target recognition.
Cas9 and gRNA were constructed using PCR and 
yeast recombination (Additional file  1: Figure S1), and 
both Cas9 and gRNA were transiently transfected with a 
donor vector/plasmid. Donor plasmids were constructed 
using PCR and yeast recombination (Additional file  1: 
Figure S1, Figure  2a). We designed two separate con-
structs to: (1) drive the expression of clr-2 with β-tubulin 
(NCU04054) promoter, and (2) drive the expression of 
codon optimized fire fly luciferase [15] with the glyco-
gen synthase-1 (gsy-1: NCU06687) promoter. CLR-2 is a 
zinc binuclear cluster transcription factor that regulates a 
large number of cellulases in N. crassa [16], and Glycogen 
Synthase-1 (GSY-1) is an enzyme that converts glucose 
into glycogen [17]. β-tubulin-clr-2 and gsy-1-luciferase 
sequences were followed by the bar gene for selection 
using Ignite® (glufosinate), and they were targeted to its 
endogenous locus and csr-1 locus, respectively. csr-1 is 
a commonly used locus for transformation in N. crassa. 
Gene replacement of the csr-1 gene, which encodes the 
cyclosporin A-binding protein, leads to resistance to 
cyclosporin A [18].  The strains used in this study are 
listed in Table 1. 
As a proof of principle, we set out to test overexpres-
sion of cellulases with the β-tubulin promoter-driven 
expression of clr-2, and efficient selection of lucif-
erase reporters with a bioluminescence assay. 5  μg of 
β-tubulin-clr-2 circular donor plasmids were trans-
formed into wild type N. crassa (74-OR23-1 V A) along 
with different concentrations of Cas9 and gRNA circular 
plasmids (Figure  2b). Transformations were performed 
as previously described [19]. Dose-dependent increase 
of the number of transformants of β-tubulin-clr-2 was 
obtained by addition of Cas9 and gRNA (Figure 2b; Cas9 
and gRNA plasmids: 0  µg: 1.0  ±  0.6; 1  µg: 0.8  ±  0.5; 
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Figure 1 System overview of genomic edition in N. crassa using CRISPR/Cas9. a The system consists of two components, a Cas9 protein and a sin‑
gle crRNA:tracrRNA chimeric guide RNA (gRNA), comprising a 20‑bp target sequence (red) complementary to the genomic target adjacent to a PAM 
site of NGG (blue). b Design of the Cas9 and gRNA constructs. The Cas9 protein contained a SV40 nuclear localization signal, and the expression was 
under the control of the trpC promoter and terminator. The gRNA was expressed under the snoRNA SNR52 promoter and contained a terminator 
from the 30 region of the yeast SUP4 gene. c Design of gRNA targeted to clr‑2 and csr‑1 loci.
Table 1 Strains used in this study
Strain FGSC# or reference Mating type Genotype
74‑OR23‑1V A 987 A Wild type (WT)
328‑4 Belden et al. [20] a ras‑1 bd
mus‑51 KO 20277 a Δmus‑51
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Tukey’s method). We utilized optimal concentrations 
(5  µg) of Cas9 and gRNA with gsy-1-luciferase::csr-1 
donor plasmid to transform the ras-1bd N. crassa strain 
[20] (Figure  2c). gsy-1-luciferase::csr-1 that targets csr-1 
locus enables double selection for both Ignite® and cyclo-
sporine A as previously described [21]. As expected, we 
observed an efficient number of transformants of gsy-
1-luciferase::csr-1 with optimized concentrations (Fig-
ure 2c; Cas9 and gRNA plasmids: 0 µg: 3.7 ±  1.9; 1 µg: 
364.0 ± 33.1; n = 3, p < 0.01; Student’s t test). The trans-
formants produced with the CRISPR/Cas9 system suc-
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Figure 2 Evaluation of CRISPR/Cas9 system for transformation of N. crassa. a Diagram of donor plasmids. Blue color regions are the sequence 
regions that are homologous to genomic DNA. Bar gene cassette which contains the bar gene under the control of trpC promoter and terminator 
was included in each plasmids for selection. b The number of Ignite‑resistant colonies by clr‑2 locus targeted transformation with different amount 
of Cas9 and gRNA plasmids. From left to right: zero, 1, 2.5, and 5 µg each of Cas9 and gRNA plasmid was co‑transfected with the donor plasmid 
(5 µg). **p < 0.01, Tukey’s test. Error bars corresponds to the SEM. c The number of Ignite‑resistant colonies by csr‑1 locus targeted transformation 
with zero and 5 µg each of Cas9 and gRNA plasmids. **p < 0.01, student’s t‑test. Error bars corresponds to the SEM. d–f Luciferase activity on the 
plates of gsy‑1‑luciferase transformants. Luciferase signal (d), under red‑light (e), and merged (f) images are shown.
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were plated onto luciferin containing plates, and in vivo 
luciferase activities were monitored with a charge-cou-
pled device camera. We observed 57 luciferase positive 
colonies out of 1,092 total colonies with CRISPR/Cas9 
system, but no positive colonies were observed with non-
CRISPR/Cas9 method of transformation [11, 19] (Fig-
ure 2d–f). The reason for low number of positive colonies 
with bioluminescence assay is due to the small sizes of 
other colonies, which do not produce detectable signals.
Next, we assessed the efficiency of HR in 74-OR23-
1V A with the CRISPR/Cas9 system versus mus-51 KO 
with the traditional method [10]. We observed efficient 
transformations with both methodologies (Figure  3a; 
mus-51 KO: 23 ±  56; CRISPR/Cas9: 66 ±  103; n =  4). 
Successful transformants at the clr-2 locus were vali-
dated through polymerase-chain reaction (PCR) analysis 
(see Table  2 for primers used in this study). The trans-
formants were grown in liquid culture media, and we 
did not observe any differences of growth between the 
transformants from both methodologies. The genomic 
DNA was extracted from the transformants with either 
74-OR23-1V A or mus-51 KO background, and quanti-
tative PCR (qPCR) analysis was performed to count the 
number of transgenes in the genome. Similar number 
of transformants showed more than one clr-2 in their 
genome from both methods (CRISPR/Cas9: 6/20; mus-51 
KO: 7/20; Figure 3b). As a control, we tested the number 
of gh6-2 in each genome and confirmed that none of the 
transformants had more than one gh6-2 (Figure 3c). The 
transformants with single clr-2 in their genome were fur-
ther validated by PCR to confirm the β-tubulin promoter 
fused to clr-2 gene (Figure 3d). Interestingly, we observed 
three transformants from each method that exhibit the 
correct HR events at the clr-2 locus (CRISPR/Cas9: 3/14; 
mus-51 KO: 3/13; Figure 3e).
Lastly, we tested the expression of cellulases in N. crassa 
carrying a targeted insertion of the β-tubulin promoter-
regulated clr-2 (transformant #14 from the right panel 
of Figure 3e). We observed approximately two hundred-
fold increase of clr-2 mRNA expression in the β-tubulin-
clr-2 strain compared to wild type in 2% glucose as a sole 
carbon source, which indicates successful overexpres-
sion of clr-2 using the β-tubulin promoter (Figure  4a; 
188.2  ±  52.8-fold; n  =  3, p  <  0.01; Student’s t-test). 
Increased expression was found for cbh-1 (NCU07340), 
gh5-1 (NCU00762), and gh6-2 (NCU09680) mRNA (Fig-
ure 4b–d; cbh-1: 68.3 ± 25.5-fold; gh5-1: 1724.3 ± 538.1-
fold; gh6-2: 14.6  ±  5.3-fold; n  =  3, p  <  0.01; Student’s 
t-test; see Table 2 for primers used in this study). CBH-1 
and GH6-2 are exoglucanases, and GH5-1 is an endoglu-
canase that facilitate degradation of cellulose [22].
In this report, we successfully demonstrated effi-
cient gene replacements utilizing CRISPR/Cas9 tech-
nology in a model filamentous fungus, N. crassa. N. 
crassa did not indicate any problems in expressing 
functional Cas9 endonuclease under the A. nidulans 
trpC promoter, and the SNR52 promoter is operational 
to express gRNA in N. crassa as in S. cerevisiae [14]. 
These events enabled us to perform efficient knock-in 
of clr-2 with β-tubulin promoter and target gsy-1-lu-
ciferase bioluminescence reporter at the csr-1 locus 
with relatively simple modifications of template plas-
mids utilizing PCR and yeast recombination. In con-
trast to previously established gene editing protocols in 
Table 2 Primers used in this study
Primer name Sequence 5′-3′ Used for
β‑tubulin‑p F TGCGACCAGGTTCAGGAGAGC Genomic PCR (Figure 3e)
actin F GTCCCCGTCATCATGGTATC qRT‑PCR (Figure 4)
actin R CTTCTCCATGTCGTCCCAGT qRT‑PCR (Figure 4)
clr‑2 F GCACCATCAATGTCGATACCTAC qPCR, qRT‑PCR (Figures 3b; 4a)
clr‑2 R1 CATTGGCCACATGGTTGTTGACC qPCR (Figure 3b, e)
clr‑2 R2 CCATCACACCGAATCTTTCGTCT qRT‑PCR (Figure 4a)
cbh‑1 F CTGCGTTGATGGTGCTGAGTAC qRT‑PCR (Figure 4b)
cbh‑1 R GAGCTCGAAGCCCTGGTAGG qRT‑PCR (Figure 4b)
gh5‑1 F CTCCTGCTAGCACCACCACTG qPCR, qRT‑PCR (Figures 3b, c; 4c)
gh5‑1 R1 CAAGGCGCTCCATGGCGAAG qPCR (Figure 3b, c)
gh5‑1 R2 CTGCGGAGAGTCTGGATGGTG qRT‑PCR (Figure 4c)
gh6‑2 F GCTCTGCCTGGAGCCAGTG qPCR, qRT‑PCR (Figures 3c; 4d)
gh6‑2 R1 GTGGTGGTAACCTGAGCGCC qPCR (Figure 3c)
gh6‑2 R2 CTTGCTGGTGGTGCTAGAG qRT‑PCR (Figure 4d)
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Neurospora, CRISPR/Cas9 technology did not require 
mus-51 or mus-52 mutant backgrounds for efficient 
HR. This technology will enable efficient gene editing 
of any Neurospora natural isolates. Recent advance-
ment and ramifications of CRISPR/Cas9 technology 
created numerous resources including multiplex gene 
replacements, transcriptional control, and inducible 
gene regulation [4]. Implementation of this technol-
ogy in fungal organisms will be highly beneficial for the 
fungal research community.
-tubulin  
























































































mus-51 KO WT (CRISPR/Cas9) 
mus-51 KO WT (CRISPR/Cas9) 
mus-51 KO WT 
WT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
WT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 WT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
0281716151413101865431TW02817161311101876541TW
d 
e mus-51 KO WT (CRISPR/Cas9) 
clr-2 R -tubulin-p F 
Figure 3 Rate of homologous integration at clr‑2 locus in wild type with CRISPR/Cas9 technology versus mus‑51 KO with the traditional method. 
a The number of Ignite‑resistant colonies by clr‑2 locus targeted transformation in the mus‑51 KO and wild type (WT: 74‑OR23‑1V A) with CRISPR/
Cas9. Error bars corresponds to the SEM. b qPCR analysis to assess the number of clr‑2 in genomic DNA from the transformants with either WT (right 
panel) or mus‑51 KO backgrounds (left panel). Error bars corresponds to the SEM. c qPCR analysis to assess the number of gh6‑2 in genomic DNA 
from the transformants with either WT (right panel) or mus‑51 KO backgrounds (left panel). Error bars corresponds to the SEM. d Schematic overview 
of the priming sites for PCR analysis to confirm the connection of β‑tubulin promoter and clr‑2. e PCR assay using β‑tubulin‑p F and clr‑2 R primers. 
Expected fragment size: 1,343 bp.
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Materials and methods
Materials and methods and any associated references are 
available in the online version of the paper at http://www.
fungalbiolbiotech.com/ (Additional file 2).
Additional files
 Additional file1: Figure S1. Full plasmid sequences of the Cas9, gRNA, 
and donor vectors. Green, orange, blue, red, light blue, gray letters indicate 
the promoter, coding sequence, terminator, gRNA, homologous region, 
and bar gene cassette, respectively. 20‑bp target sequences in gRNA are 
underlined.
Additional file 2. Materials and methods.
Abbreviations
CRISPR: clustered regularly interspaced short palindromic repeats; gRNA: 
single crRNA:tracrRNA chimeric guide RNA; KO: knockout; NLS: nuclear locali‑
zation signal; SNR52: small nucleolar RNA 52; PAM: protospacer adjacent motif; 
gsy‑1: glycogen synthase‑1; HR: homologous recombination; PCR: polymerase 
chain reaction; qPCR: quantitative polymerase chain reaction; qRT‑PCR: quan‑
titative reverse transcription polymerase chain reaction; SEM: standard error of 
the mean; n: number of experiments.
Authors’ contributions
TM designed the experiments. TM, MB, and JK performed experiments. CH 
and TM supervised the overall experiments and wrote the manuscript. All 
authors read and approved the final manuscript.
Author details
1 Department of Molecular and Cellular Physiology, University of Cincin‑
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Figure 4 Amplified expression of cellulase genes by enhanced expression of clr‑2 with β‑tubulin promoter. The mRNA expression of clr‑2 and cel‑
lulase genes are measured by qRT‑PCR. The expression of clr‑2 (a), cbh‑1 (b), gh5‑1 (c), and gh6‑2 (d) are shown. White and black bars show mRNA 
expressions in wild type (WT: 74‑OR23‑1V A) and β‑tubulin‑clr‑2 strains, respectively. Each strain is cultured in the media containing 2% glucose as a 
sole carbon source. All the expressions were normalized by the expressions in WT. **p < 0.01, student’s t‑test. Error bars corresponds to the SEM.
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